ACR Poker boosts Moneymaker Month with two new supersized events, expanding million-dollar action alongside the Mystery Million series.
• Initial ACR-368 Phase 2b clinical data in patients with ovarian or endometrial cancers (n=26; 10 OncoSignature-positive and 16 OncoSignature-negative) are being presented• A 50% confirmed overall ...
PEPN1924, A Phase II Study of Trastuzumab Deruxtecan in Patients With Recurrent Human Epidermal Growth Factor Receptor 2+ Osteosarcoma: A Children's Oncology Group Pediatric Early-Phase Clinical Trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback